2022
DOI: 10.1016/j.adro.2021.100835
|View full text |Cite
|
Sign up to set email alerts
|

Telemedicine Use and Satisfaction Among Radiation Oncologists During the COVID-19 Pandemic: Evaluation of Current Trends and Future Opportunities

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
29
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(37 citation statements)
references
References 26 publications
2
29
0
2
Order By: Relevance
“…These figures are consistent with previously reported high satisfaction rates (74%-100%) and interest (82%-89%) in continuing to offer telemedicine after the pandemic ends among other radiation oncologists. 2 , 4 , 5 , 8 Motivators driving telemedicine utilization included patient and provider preference, the ability to improve access to both standard-of-care radiation treatments and clinical trials, and improved clinical safety and efficiency. Patient factors most often considered when determining to use telemedicine included patient convenience, cost-effectiveness (consistent with prior reports), 17 and patient attitudes toward telemedicine.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…These figures are consistent with previously reported high satisfaction rates (74%-100%) and interest (82%-89%) in continuing to offer telemedicine after the pandemic ends among other radiation oncologists. 2 , 4 , 5 , 8 Motivators driving telemedicine utilization included patient and provider preference, the ability to improve access to both standard-of-care radiation treatments and clinical trials, and improved clinical safety and efficiency. Patient factors most often considered when determining to use telemedicine included patient convenience, cost-effectiveness (consistent with prior reports), 17 and patient attitudes toward telemedicine.…”
Section: Discussionmentioning
confidence: 99%
“…Telemedicine offers the potential for a range of benefits, including improvements in clinical outcomes, quality and safety, access to care, financial and operational impact, health equity, and patient, family and clinician experience. 1 Although telemedicine was implemented in limited settings before the COVID-19 pandemic, 2 U.S. radiation oncology (RO) practices dramatically increased their use of telemedicine in early 2020, 3 , 4 , 5 partly out of concern for viral transmission and partly due to temporary waivers that eased payment and privacy restrictions for Medicare providers. 6 …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Telemedicine, which is seen as a precaution taken during the pandemic period due to the risky environment in hospitals, has played an important role in promoting remote patient-physician communication and reducing the transmission of the virus ( Damico et al, 2021 ). Telemedicine applications can accelerate the transformative effect of technology in the field of medicine during the pandemic period.…”
Section: Discussionmentioning
confidence: 99%
“…La aceptación de la TC por parte de los pacientes es elevada, como demuestran varios trabajos publicados recientemente en los que se analizado la asistencia remota recibida durante la pandemia por coronavirus [27,28]. La alta satisfacción manifestada por los usuarios, los beneficios constatados y la gran resolución de las teleconsultas, ha llevado a plantearse ampliar estos servicios tras la pandemia, especialmente para la entrega de resultados de pruebas y valoración del control de una enfermedad.…”
Section: Teleconsultaunclassified